Clinical Trials Directory

Trials / Completed

CompletedNCT01263977

Thermodilution - Controlled Management of Volume Therapy in Septic Shock

A Randomized Mono-center Study Looking at the Effect of Thermodilution Controlled Therapy for Volume Optimization on the Duration of Septic Shock in Patients With Septic Shock

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Claudia Spies · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Septic shock and multi-organ failure are among the most frequent causes of death in the ICU. Patients with septic shock require early implementation of hemodynamic therapy to keep the duration of shock state and with it microcirculatory disturbances as short as possible. In the septic shock guidelines by the american association SCCM the diagnosis of volume status is based on filling pressures, like CVP. Some studies show, that the CVP depends not only on the intravascular volume, but also on the right ventricular compliance, pulmonary vascular resistance as well as intrathoracic pressure. The aim of the Study is to evaluate if the duration of septic shock can be reduced through algorithm driven volume therapy orientated to thermodilution based volume parameters (GEDI and ELWI)

Conditions

Interventions

TypeNameDescription
DEVICEPicco- thermodilution catheterTranspulmonary thermodilution and pulse contour analysis with arterial catheter Arterial access via femoral

Timeline

Start date
2010-12-01
Primary completion
2014-05-01
Completion
2014-05-01
First posted
2010-12-21
Last updated
2014-06-06

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01263977. Inclusion in this directory is not an endorsement.